Metastatic Cancer Drug Market: Solid Growth as Targeted Therapies and Immunotherapies Reshape Treatment of Advanced Disease
The Metastatic Cancer Drug Market is expanding steadily as targeted therapies and immunotherapies become central to managing advanced cancers. One widely cited analysis values the global metastatic cancer drugs market at about USD 78.75–80.13 billion in 2024–2025, with forecasts reaching USD 120.8–123.5 billion by 2030–2031, at CAGRs around 7.3–7.5%. Some...
0 Commentaires 0 Parts 72 Vue 0 Aperçu
G-NTZ6Y6K0XV
Social Network https://socialbroad.com